99Tcm-sestamibi as an agent for imaging P-glycoprotein-mediated multi-drug resistance: in vitro and in vivo studies in a rat breast tumour cell line and its doxorubicin-resistant variant.
about
Imaging recognition of inhibition of multidrug resistance in human breast cancer xenografts using 99mTc-labeled sestamibi and tetrofosmin.Imaging recognition of multidrug resistance in human breast tumors using 99mTc-labeled monocationic agents and a high-resolution stationary SPECT system.Evaluation of (99m)technetium-mebrofenin and (99m)technetium-sestamibi as specific probes for hepatic transport protein function in rat and human hepatocytesThe effect of radiation exposure on multidrug resistance: in vitro and in vivo studies using non-small lung cancer cellsBMS181321 accumulation in rodent and human cells: the role of P-glycoprotein.Comparison of (99m)Tc-sestamibi and doxorubicin to monitor inhibition of P-glycoprotein function.Transport processes of radiopharmaceuticals and -modulators.Is (99m)Tc-MIBI scintigraphy a predictor of response to pre-operative neoadjuvant chemotherapy in Osteosarcoma?The use of 99mTc-MIBI scanning in multiple myeloma.99mTc-sestamibi is a substrate for P-glycoprotein and the multidrug resistance-associated protein.Molecular Imaging of P-glycoprotein in Chemoresistant Tumors Using a Dual-Modality PET/Fluorescence Probe.Multidrug resistance phenotype in leukaemic cells from patients with acute myelocytic leukaemia can be detected with 99Tc(m)-MIBI.
P2860
Q34450507-515774CF-2D65-41E4-83F8-6012D99BD373Q34711648-3B1FDC5A-EB89-4CE3-9BA1-6CAF7DC92B25Q35086354-C3CFD62F-76C5-4AD3-8084-A5D9221ED68FQ35267029-69326E91-1771-45BC-84F8-1F5718B607AFQ36291908-BEF7F208-EE31-4D82-9924-A7CA51D4847BQ36622566-53DA0DB0-1878-469A-99BE-3E8B9E5A3E5FQ37885468-3FC5B05A-2261-4CD1-AF6E-D948341FAB96Q39607661-D5FDE255-7399-4163-817B-B90BE2B8365BQ40073883-5AF5E79D-4140-408A-A00A-79CEA47C13B3Q41064272-82EEA756-E339-4428-BF07-CE6339C4445BQ42798231-2C6BDCF4-6B9C-43FA-8392-A5D45A636D05Q42859166-404DCABA-1DE4-4C6C-B18B-4AF19F28B8B6
P2860
99Tcm-sestamibi as an agent for imaging P-glycoprotein-mediated multi-drug resistance: in vitro and in vivo studies in a rat breast tumour cell line and its doxorubicin-resistant variant.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
99Tcm-sestamibi as an agent fo ...... doxorubicin-resistant variant.
@en
type
label
99Tcm-sestamibi as an agent fo ...... doxorubicin-resistant variant.
@en
prefLabel
99Tcm-sestamibi as an agent fo ...... doxorubicin-resistant variant.
@en
P2093
P1476
99Tcm-sestamibi as an agent fo ...... doxorubicin-resistant variant
@en
P2093
P304
P356
10.1097/00006231-199504000-00156
P577
1995-04-01T00:00:00Z